Literature DB >> 8631643

Extracellular matrix alterations in human corneas with bullous keratopathy.

A V Ljubimov1, R E Burgeson, R J Butkowski, J R Couchman, R R Wu, Y Ninomiya, Y Sado, E Maguen, A B Nesburn, M C Kenney.   

Abstract

PURPOSE: To uncover abnormalities of extracellular matrix (ECM) distribution in human corneas with pseudophakic and aphakic bullous keratopathy (PBK/ABK).
METHODS: Indirect immunofluorescence with antibodies to 27 ECM components was used on frozen sections of 14 normal and 20 PBK/ABK corneas.
RESULTS: Fibrillar deposits of an antiadhesive glycoprotein tenascin in the anterior and posterior stroma, epithelial basement membrane (BM), bullae and subepithelial fibrosis (SEF) areas, and posterior collagenous layer (PCL) were revealed in disease corneas. Tenascin in midstroma, which was observed in some cases, correlated with decreased visual acuity. In normal central corneas, tenascin was never found. Other major ECM abnormalities in PBK/ABK corneas compared to normals included: discontinuous epithelial BM straining for laminin-1 (alpha 1 beta 1 gamma 1), entactin/nidogen and fibronectin; accumulation of fibronectin and alpha 1-alpha 2 type IV collagen on the endothelial face of the Descemet's membrane; and abnormal deposition of stromal ECM (tenascin, fibronectin, decorin, types I, III, V, VI, VIII, XII, XIV collagen) and BM components (type IV, collagen, perlecan, bamacan, laminin-1, entactin-nidogen, fibronectin) in SEF areas and in PCL.
CONCLUSIONS: The study provides a molecular description of an ongoing fibrosis on the epithelial, stomal, and endothelial levels in PBK/ABK corneas. These fibrotic changes may follow initial endothelial damage after cataract surgery, may be caused by the upregulation of fibrogenic cytokines, and may play a significant role in the progression of bullous keratopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631643

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

1.  Proteoglycan expression during transforming growth factor beta -induced keratocyte-myofibroblast transdifferentiation.

Authors:  J L Funderburgh; M L Funderburgh; M M Mann; L Corpuz; M R Roth
Journal:  J Biol Chem       Date:  2001-09-12       Impact factor: 5.157

2.  Effects of the matrix metalloproteinase inhibitor GM6001 on the destruction and alteration of epithelial basement membrane during the healing of post-alkali burn in rabbit cornea.

Authors:  Tadashi Kato; Shizuya Saika; Yoshitaka Ohnishi
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.447

3.  Anterior keratocyte depletion in fuchs endothelial dystrophy.

Authors:  Laura A Hecker; Jay W McLaren; Lori A Bachman; Sanjay V Patel
Journal:  Arch Ophthalmol       Date:  2011-01-10

Review 4.  Integrins and vascular extracellular matrix assembly.

Authors:  E Ruoslahti; E Engvall
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  Long-term symptomatic relief of bullous keratopathy with amniotic membrane transplant.

Authors:  Gillian D J Y Siu; Alvin L Young; Lulu L Cheng
Journal:  Int Ophthalmol       Date:  2015-01-14       Impact factor: 2.031

6.  Abnormal corneal endothelial maturation in collagen XII and XIV null mice.

Authors:  Chinda Hemmavanh; Manuel Koch; David E Birk; Edgar M Espana
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-07       Impact factor: 4.799

7.  The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea.

Authors:  A Tuori; I Virtanen; E Aine; H Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

8.  Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy.

Authors:  S Akhtar; A J Bron; N R Hawksworth; R E Bonshek; K M Meek
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

9.  Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas.

Authors:  Barbara Strzalka-Mrozik; Agnieszka Stanik-Walentek; Malgorzata Kapral; Malgorzata Kowalczyk; Jolanta Adamska; Joanna Gola; Urszula Mazurek
Journal:  Mol Vis       Date:  2010-02-05       Impact factor: 2.367

10.  Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway.

Authors:  Elaine L Shay; Charles A Greer; Helen B Treloar
Journal:  Dev Dyn       Date:  2008-07       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.